Incidence of gynecomastia in men infected with HIV and treated with highly active antiretroviral therapy.
A longitudinal study found that the incidence of gynecomastia in HIV-infected male patients treated with highly active antiretroviral therapy was 0.8/100 patient-years, with a prevalence of 2.8% in those treated for > or = 2 y. Even though the physiopathology remains unclear, this study suggests that gynecomastia should be monitored in these patients.
Piroth
L
L
Department of Infectious Diseases, University Hospital of Dijon, France.
Grappin
M
M
Petit
J M
JM
Buisson
M
M
Duong
M
M
Chavanet
P
P
Portier
H
H
D000328:Adult; D023241:Antiretroviral Therapy, Highly Active / Q000009:adverse effects*; D005602:France / Q000453:epidemiology; D006177:Gynecomastia / Q000139:chemically induced* / Q000453:epidemiology; D015658:HIV Infections / Q000188:drug therapy; D006801:Humans; D015994:Incidence; D008137:Longitudinal Studies; D008297:Male; D008875:Middle Aged; D015995:Prevalence